Functional consequence of MDR1 expression on imatinib intracellular concentrations

被引：60

作者：

Widmer, N ^{[1
]}

Colombo, S ^{[1
]}

Buclin, T ^{[1
]}

Decosterd, LA ^{[1
]}

机构：

[1] CHU Vaudois, Univ Hosp, Div Clin Pharmacol, CH-1011 Lausanne, Switzerland

来源：

BLOOD | 2003年 / 102卷 / 03期

关键词：

D O I：

10.1182/blood-2003-03-0993

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1142 / 1142

页数：1

共 9 条

[1] Glivec (ST1571, Imatinib), a rationally developed, targeted anticancer drug [J].

Capdeville, R ;

Buchdunger, E ;

Zimmermann, J ;

Matter, A .

NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (07) :493-502

[2] Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDR1 and MRP1 [J].

Hegedüs, T ;

Örfi, L ;

Seprödi, A ;

Váradi, A ;

Sarkadi, B ;

Kéri, G .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2002, 1587 (2-3) :318-325

[3] Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571:: diverse mechanisms of resistance [J].

Mahon, FX ;

Deininger, MWN ;

Schultheis, B ;

Chabrol, J ;

Reiffers, J ;

Goldman, JM ;

Melo, JV .

BLOOD, 2000, 96 (03) :1070-1079

[4] MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models [J].

Mahon, FX ;

Belloc, F ;

Lagarde, V ;

Chollet, C ;

Moreau-Gaudry, F ;

Reiffers, J ;

Goldman, JM ;

Melo, JV .

BLOOD, 2003, 101 (06) :2368-2373

[5] Mechanisms of resistance to imatinib mesylate in Bcr-Abl-positive leukemias [J].

Nimmanapalli, R ;

Bhalla, K .

CURRENT OPINION IN ONCOLOGY, 2002, 14 (06) :616-620

[6] EXPRESSION OF THE MULTIDRUG RESISTANCE GENE IN MYELOID LEUKEMIAS [J].

SATO, H ;

GOTTESMAN, MM ;

GOLDSTEIN, LJ ;

PASTAN, I ;

BLOCK, AM ;

SANDBERG, AA ;

PREISLER, HD .

LEUKEMIA RESEARCH, 1990, 14 (01) :11-&

[7] ABSENCE OF THE MDR1A P-GLYCOPROTEIN IN MICE AFFECTS TISSUE DISTRIBUTION AND PHARMACOKINETICS OF DEXAMETHASONE, DIGOXIN, AND CYCLOSPORINE-A [J].

SCHINKEL, AH ;

WAGENAAR, E ;

VANDEEMTER, L ;

MOL, CAAM ;

BORST, P .

JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (04) :1698-1705

[8] Prognostic value of P-glycoprotein and leukocyte differentiation antigens in chronic myeloid leukemia [J].

Stavrovskaya, A ;

Turkina, A ;

Sedyakhina, N ;

Stromskaya, T ;

Zabotina, T ;

Khoroshko, N ;

Baryshnikov, A .

LEUKEMIA & LYMPHOMA, 1998, 28 (5-6) :469-482

[9] In vitro and in vivo models for assessing drug efflux transporter activity [J].

Zhang, Y ;

Bachmeier, C ;

Miller, DW .

ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (01) :31-51

← 1 →